#lipitor

[jilli1205]

What to know about the recall of atorvastatin pills for lowering cholesterol

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

[wtf-fun-factss]

Lipitor (Atorvastatin) is the best-selling drug of all time. Between when it was introduced in 1997 and its patent expiration in 2011, it generated ~$125 billion in sales for Pfizer. In 2018, it was the most commonly prescribed medication in the US, with more than 112 million prescriptions. – WTF Fun Facts

Source: https://en.wikipedia.org/wiki/Atorvastatin

[winstontseng]

Fast Food Culture (2019)

[dragonwrangler]

140K Cholesterol Pills Recalled Over Absorption Risk

FDA recalls atorvastatin calcium tablets that may not absorb properly, possibly reducing effectiveness. Patients should consult their doctor

FDA site-

[sighphi]

What to know about the recall of atorvastatin pills for lowering cholesterol

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

[ricisidro]

Atorvastatin, manufactured by Alkem Laboratories in India and distributed by Ascend Laboratories, was recently subject to a US FDA recall due to some batches failing dissolution tests (i.e., not releasing the drug correctly). In contrast, RHEA Atorvastatin available in the Philippines is imported from the original manufacturer, Pfizer—the brand-name producer of Lipitor—suggesting it is likely sourced from Pfizer's global generic supply.

#Health #HeartHealth #Cholesterol #LDL #Stroke #Prevention

[grumpquotesdaily]

[anushkaksblog]

Global Lipitor Market Size, Trends, and Growth Outlook 2025-2032

The Lipitor market is witnessing a notable shift driven by evolving industry dynamics and changing patient preferences. With Lipitor being a leading pharmaceutical product for cholesterol management, market analysis reveals significant transformations impacting market players, growth strategies, and revenue forecasts through 2032. Market Size and Overview The Global LIPITOR Market size is estimated to be valued at USD 1,386.6 Mn in 2025 and is expected to decline to USD 937.7 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -5.4% from 2025 to 2032.

This decline in industry size underscores increasing competition from generic alternatives and emerging treatment protocols. Despite market restraints, certain market segments maintain steady demand fueled by cardiovascular disease prevalence. The LIPITOR Market Growth highlights a shrinking market revenue landscape but also identifies pockets of resilience driven by targeted market growth strategies and product lifecycle management.  

Get More Insights On – Lipitor Market